Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) founded an auxiliary – Digestix Bioscience. The new company will develop pharmaceutical compositions and medical devices to cure early-stage and precancerous neoplastic...
Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) has completed the pre-clinical development of innovative formulation that comprise cannabidiol to treat colon cancer. The innovative formulation has shown significant anti-tumor...
An R&D team of Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) has conducted a study on the combinatorial effects of the purified cannabinoids in Israel. According to study findings,...
Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) recently announced conclusion of its Cannabics SR 5mg clinical trial that took place at the Rambam Medical Center’s The Oncology Center. The...
Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) is teaming up with biopharmaceutical company that focuses in the development of working solutions for a wide range of ophthalmic disorders. The...
Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) has announced that it is collaborating with Muriel Zohar, the CEO of Life Sources Partners Ltd. The collaboration has been formed with...
